In a 71-year-old man with prior coronary artery bypass grafting (CABG) on clopidogrel, aspirin, atorvastatin, and nebivolol, who experiences mild dyspnea only when lying flat (orthopnea) with blood pressure 140/80 mmHg, pulse 78 bpm, oxygen saturation 98% sitting and 95% supine, no cough, no edema, and normal lung sounds, what is the diagnosis and appropriate treatment?

Diagnosis: Likely Early Heart Failure with Orthopnea

This patient most likely has early heart failure (HF) presenting with orthopnea, and should be evaluated with echocardiography to assess left ventricular function and initiate appropriate HF therapy if confirmed.

Clinical Reasoning

Key Diagnostic Features

The presentation is highly suggestive of early cardiac decompensation:

• Orthopnea (dyspnea when lying flat that resolves when upright) is a classic symptom of elevated left ventricular filling pressures
• Positional oxygen desaturation (98% sitting → 95% supine) indicates redistribution of blood volume when recumbent, increasing pulmonary venous pressure
• Post-CABG patient with established coronary disease on appropriate secondary prevention medications
• Absence of pulmonary findings (no cough, no edema, normal lung sounds) makes primary pulmonary pathology less likely but does not exclude early HF

The nocturnal timing ("not occurred in daytime") is particularly characteristic of paroxysmal nocturnal dyspnea or early orthopnea, both hallmarks of left ventricular dysfunction.

Differential Considerations

While the presentation strongly suggests HF, alternative diagnoses to consider include:

• Phrenic nerve injury from prior CABG (though this typically presents earlier post-operatively and would show persistent symptoms) 1
• Silent myocardial ischemia or graft failure (less likely given stable vital signs and lack of chest pain)
• Diastolic dysfunction with preserved ejection fraction (common in this age group)

Immediate Diagnostic Workup

Essential investigations to perform urgently:

1. Echocardiography - This is the critical first test to assess:

   • Left ventricular ejection fraction (LVEF)
   • Regional wall motion abnormalities suggesting graft failure
   • Diastolic function parameters
   • Valvular function (particularly mitral regurgitation)

2. BNP or NT-proBNP - Elevated levels support HF diagnosis

3. ECG - Look for:

   • New ischemic changes
   • Arrhythmias
   • Comparison with prior post-CABG baseline

4. Chest X-ray - Assess for:

   • Cardiomegaly
   • Pulmonary vascular congestion
   • Diaphragm position (to exclude phrenic nerve paralysis)

5. Troponin - Rule out acute coronary syndrome

Treatment Algorithm

If LVEF ≤40% (Reduced Ejection Fraction HF)

Immediate management:

• Continue current medications (aspirin, clopidogrel, atorvastatin, nebivolol) 2
• Add ACE inhibitor or ARB - Start low dose and titrate (e.g., enalapril 2.5 mg twice daily or ramipril 1.25 mg daily)
• Add aldosterone antagonist if LVEF <35% and no contraindications (spironolactone 12.5-25 mg daily)
• Optimize beta-blocker - Nebivolol is already prescribed; ensure adequate dosing for HF (target 5-10 mg daily) 3
• Consider loop diuretic if evidence of volume overload develops (furosemide 20-40 mg daily) 4

Critical warning about nebivolol: Do not abruptly discontinue in this patient with coronary artery disease, as severe exacerbation of angina, MI, and ventricular arrhythmias can occur 3. If medication adjustment is needed, taper over 1-2 weeks.

If LVEF >40% (Preserved Ejection Fraction HF)

Management focuses on:

• Blood pressure control - Current BP 140/80 mmHg is acceptable but could be optimized to <130/80 mmHg
• Continue statin therapy - Atorvastatin should be continued at high intensity to achieve LDL-C <70 mg/dL 2, 5
• Diuretics as needed for symptom relief
• Treat underlying causes (ischemia, hypertension, atrial fibrillation if present)

If Echocardiography Shows Normal Function

Consider:

1. Stress testing to evaluate for inducible ischemia or graft failure
2. Coronary angiography if LVEF >40% and stress test positive, or if LVEF ≤40% 6
3. Fluoroscopy or ultrasound to assess diaphragmatic motion if phrenic nerve injury suspected 1

Medication Optimization

Current Regimen Assessment

The patient's current medications are appropriate for post-CABG secondary prevention:

• Aspirin + Clopidogrel: Continue dual antiplatelet therapy (DAPT) for 12 months post-CABG 2
• Atorvastatin: Maintain high-intensity statin therapy targeting LDL-C <70 mg/dL 2, 5
• Nebivolol: Appropriate beta-blocker for both hypertension and potential HF; do not discontinue abruptly 3

Key Medication Considerations

Statin therapy: High-intensity statin should be continued indefinitely. Atorvastatin has demonstrated reduction in major cardiovascular events, stroke, and MI in patients with established CAD 5. The combination with clopidogrel is safe and effective 7, 8.

Beta-blocker management: Nebivolol provides cardioprotection but must be continued carefully. If HF is confirmed and symptoms worsen despite therapy, consider switching to a more evidence-based HF beta-blocker (carvedilol, metoprolol succinate, or bisoprolol) rather than discontinuing 4.

Follow-up Strategy

Within 1-2 weeks:

• Review echocardiography results
• Assess response to any initiated HF therapy
• Check renal function and electrolytes if ACE inhibitor or diuretic started
• Verify LDL-C levels and adjust statin if needed

Within 3 months:

• Repeat echocardiography if initial LVEF was reduced
• Consider coronary angiography if symptoms persist or worsen despite optimal medical therapy
• Evaluate for device therapy (ICD, CRT) if LVEF remains ≤35% despite 3 months of optimal medical therapy

Critical Pitfalls to Avoid

1. Do not attribute orthopnea to "normal aging" - This symptom warrants thorough cardiac evaluation
2. Do not stop beta-blocker abruptly - Risk of rebound ischemia and arrhythmias in post-CABG patients 3
3. Do not delay echocardiography - This is the key diagnostic test that will guide all subsequent management
4. Do not assume graft patency - Post-CABG patients can develop graft failure; maintain high index of suspicion
5. Do not overlook volume status - Absence of peripheral edema does not exclude HF; pulmonary congestion can occur without systemic congestion